MPO and obstructive sleep apnea syndrome: The findings support the idea of persistent local inflammation in OSA patients, highlighting the potential value of salivary MPO levels as indicators of oropharyngeal inflammation in OSA (31).In clinical scenarios, OSA is closely associated with cardiovascular diseases, and Continuous CPAP therapy is a primary treatment approach.